Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 12.50
Ask: 13.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.00%)
Open: 13.00
High: 0.00
Low: 0.00
Prev. Close: 13.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

11 Apr 2017 07:00

RNS Number : 0758C
Carclo plc
11 April 2017
 

 

 

Carclo plc

("Carclo" or the "Group") 

 

Year End Trading Update

 

The Board is pleased to confirm that, following the anticipated strong second half performance, the Group has delivered good growth for the year ended 31 March 2017, with trading in line with the Board's expectations.

 

Technical Plastics has delivered another year of growth and operating margin improvement, with margins expected to be at or close to the Group's stated 10% target. The integration of the recently acquired Precision Tool and Die business has progressed well, and the first tranche of synergistic projects is now underway. The Division's strategy of expanding its sites, increasing its penetration into the Global Top 20 medical device companies and driving margin enhancement is proceeding well.

 

The LED division's Wipac business has continued to win new lighting programmes and we are pleased to announce that we have been awarded a second mid-volume project, on a vehicle for the hybrid market. Reflecting its less complex design than the first mid-volume project, this programme is of lower value but does not require any material working capital investment by the Group. This win endorses our strategy to move into the mid-volume sector, in which the Board is confident of continued success.

 

The acquisition of FLTC (Europe) a.s. ("FLTC") was announced and completed on 30 March 2017 and the positive customer response to this extension of our capabilities has been very encouraging.

 

Group net debt at the year-end was broadly in line with our previous expectations, as adjusted for the net cash effect of the FLTC acquisition.

Carclo expects to report its preliminary results for the year ended 31 March 2017 on 6 June 2017.

 

The information contained within this announcement is deemed by Carclo plc to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

 

Ends

For further information please contact:

Carclo plc

0192 426 8040

Chris Malley, Chief Executive

 

Robert Brooksbank, Finance Director

 

 

 

Peel Hunt LLP (Corporate broker)

020 7418 8900

Justin Jones

 

Matthew Brooke-Hitching

 

 

 

Weber Shandwick Financial (Financial PR)

020 7067 0700

Nick Oborne

 

 

About Carclo

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there are significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFEFFSFWSEEL
Date   Source Headline
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:42 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.